The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study - PubMed (original) (raw)
The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study
Erik Messamore et al. Schizophr Res. 2003.
Abstract
Niacin dilates cutaneous blood vessels, resulting in a pronounced skin flush in most people. The flush response to niacin is attenuated in schizophrenia, but the quantification and physiological mechanism of this abnormality have not been described in detail. It is not clear whether the mechanism involves changes in the pharmacological sensitivity to niacin, or whether there is a reduced ability of the vasculature to dilate adequately in subjects with schizophrenia. We address this question in the present study by characterizing the dose-response relationship between topically applied alpha-methylnicotinate (AMN) and cutaneous blood flow changes, which were quantified by laser Doppler flowmetry. The dose-response curve was shifted to the right in subjects with schizophrenia. The EC(50) value of AMN was significantly increased in the schizophrenia group (mean: 1.66 mM; 95% confidence interval: 1.04-2.65 mM) as compared to the control group (mean: 0.38 mM; 95% confidence interval: 0.263-0.547 mM). The blood flow responses to higher AMN doses were lower in the schizophrenics; however, there was no statistically significant difference in the extrapolated maximal blood flow response value (F(max)) between the two groups. The results suggest that the skin flush abnormality in schizophrenia primarily reflects reduced pharmacological sensitivity to niacin rather than an inadequate cutaneous vasodilatory response to the stimulus. Since vasodilatation in response to niacin requires the release of prostaglandins, the data from this study suggest that schizophrenia is associated with abnormalities in enzymes, receptors, or signal transduction mechanisms that affect the synthesis, release, or response to vasodilatory prostaglandins.
Similar articles
- Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
Messamore E. Messamore E. Prostaglandins Leukot Essent Fatty Acids. 2003 Dec;69(6):413-9. doi: 10.1016/j.plefa.2003.08.013. Prostaglandins Leukot Essent Fatty Acids. 2003. PMID: 14623495 Review. - Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Messamore E, Hoffman WF, Yao JK. Messamore E, et al. Schizophr Res. 2010 Sep;122(1-3):248-56. doi: 10.1016/j.schres.2010.03.025. Epub 2010 Apr 24. Schizophr Res. 2010. PMID: 20417059 Free PMC article. Clinical Trial. - Niacin subsensitivity is associated with functional impairment in schizophrenia.
Messamore E. Messamore E. Schizophr Res. 2012 May;137(1-3):180-4. doi: 10.1016/j.schres.2012.03.001. Epub 2012 Mar 22. Schizophr Res. 2012. PMID: 22445461 - Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
Ross BM, Hughes B, Turenne S, Seeman M, Warsh JJ. Ross BM, et al. Eur Neuropsychopharmacol. 2004 May;14(3):191-7. doi: 10.1016/S0924-977X(03)00145-7. Eur Neuropsychopharmacol. 2004. PMID: 15056478 - Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S, Buretić-Tomljanović A, Rubesa G, Tomljanović D, Gudelj L. Nadalin S, et al. Psychiatr Danub. 2010 Mar;22(1):14-27. Psychiatr Danub. 2010. PMID: 20305586 Review.
Cited by
- Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders.
Sharma V, Sharma P, Singh TG. Sharma V, et al. J Neural Transm (Vienna). 2024 Sep;131(9):1025-1037. doi: 10.1007/s00702-024-02803-0. Epub 2024 Jul 15. J Neural Transm (Vienna). 2024. PMID: 39007920 Review. - Niacin Skin Flush Backs-From the Roots of the Test to Nowadays Hope.
Sitarz R, Juchnowicz D, Karakuła K, Forma A, Baj J, Rog J, Karpiński R, Machrowska A, Karakuła-Juchnowicz H. Sitarz R, et al. J Clin Med. 2023 Feb 27;12(5):1879. doi: 10.3390/jcm12051879. J Clin Med. 2023. PMID: 36902666 Free PMC article. Review. - Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptoms.
Zhang T, Gan R, Zeng J, Ye J, Hu Y, Xu L, Wei Y, Tang X, Li C, Liu H, Chen T, Wang J. Zhang T, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1725-1736. doi: 10.1007/s00406-023-01556-3. Epub 2023 Jan 23. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36688979 - Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship.
Yu YH, Su HM, Lin SH, Hsiao PC, Lin YT, Liu CM, Hwang TJ, Hsieh MH, Liu CC, Chien YL, Kuo CJ, Hwu HG, Chen WJ. Yu YH, et al. Schizophrenia (Heidelb). 2022 Apr 20;8(1):38. doi: 10.1038/s41537-022-00252-w. Schizophrenia (Heidelb). 2022. PMID: 35853900 Free PMC article. - Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.
Ansarey SH. Ansarey SH. Front Psychiatry. 2021 Nov 30;12:771144. doi: 10.3389/fpsyt.2021.771144. eCollection 2021. Front Psychiatry. 2021. PMID: 34916973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical